Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular Clozapine for Aggression in Schizophrenia
NCT00189995Phase 3Withdrawn
- Sponsor
- Be'er Sheva Mental Health Center
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of clozapine in schizophrenia, sponsored by Be'er Sheva Mental Health Center. Status: withdrawn.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00189995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189995.